ARCHIVES

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

This article is from The Cancer Letter archive.

Vol. 08 No. 24 | June 11, 1982

Download PDF Visit The Full Archive

Related Articles

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

July 31, 2009

Funding Opportunities: Department of Defense Ovarian Cancer Research

May 5, 2000

AIDS Biological Specimens Available From NIH

November 22, 1985

Funding Mechanisms: How They Are Used

August 12, 1983

Judge Clears Way For Trial Pitting FDA Against Physicians Over First Amendment

March 24, 1995

Immunoassays For Isoenzymes

April 15, 1983